Celldex Therapeutics | CLDX - Current Liabilities

Stock Price
30.08
Daily Change
1.54 5.40%
Monthly
30.67%
Yearly
51.31%
Q1 Forecast
28.62

Celldex Therapeutics reported $50.99M in Current Liabilities for its fiscal quarter ending in December of 2025.





Current Liabilities Change Date
AbbVie USD 43.29B 3.9B Dec/2025
Agenus USD 323.49M 36.36M Dec/2025
Amgen USD 25.49B 3.7B Dec/2025
Bristol-Myers Squibb USD 28.14B 608M Sep/2025
Celldex Therapeutics USD 50.99M 4.53M Dec/2025
Glaxosmithkline GBP 28.82B 144.79M Dec/2025
Nektar Therapeutics USD 66.34M 5.05M Sep/2025
Northwest Biotherapeutics USD 87.9M 3.98M Sep/2025
Pfizer USD 36.6B 1.13B Sep/2025
Rigel Pharmaceuticals USD 94.4M 7.76M Sep/2025
Roche Holding CHF 28B 421M Dec/2025